CANADA CANCER DRUGS
April 1st, 2004
BY MONICA DOBIEA NEW therapy that involves combining two cancer drugs simultaneously has been hailed as a major breakthrough in treating tumours resistant to chemotherapy. Scientists at McGill University, in Montreal, have treated mice suffering from lymphoma with rapamycin, an antibiotic, and a traditional chemotherapy drug called doxorubicin. The combination reversed the tumours' resistance to chemotherapy, eliminating the cancer all the mice. According to Dr. Hans-Guido Wendel, author of the study, which has been featured in Nature magazine, the treatment ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.